By comparing mutation frequencies at different HADHA expression levels, we found that the mutation rates of TP53 and PTEN genes were higher in the high HADHA expression group than in the low expression group, revealing the potential role of this gene in GBM and its interactions with other genes (Fig. 1C). The gene discussed is HADHA; the disease is glioblastoma.